Two Merck Medicines Recommended for Approval in the European Union
- Details
- Category: Merck

GlaxoSmithKline will acquire Sirtris Pharmaceuticals for approximately USD720 million
- Details
- Category: GlaxoSmithKline

AstraZeneca PLC First Quarter Results 2008
- Details
- Category: AstraZeneca

Genzyme Reports Strong First-Quarter Growth
- Details
- Category: Genzyme

Novartis reports higher sales and earnings in first quarter of 2008
- Details
- Category: Novartis

Novartis announces 20% average reduction in price of malaria drug Coartem®
- Details
- Category: Novartis

The Medicines Company Reports First Quarter 2008 Financial Results
- Details
- Category: Financial

- Net revenue increased by 19% to $79.4 million for the first quarter of 2008 from $66.6 million for the first quarter of 2007.
More Pharma News ...
- Environmentally Responsible Site to Significantly Increase Company's Presence in China
- Results from phase 2b "DEEP" study in severe pre-eclampsia
- Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
- FTY720, a novel oral therapy in development for multiple sclerosis
- GlaxoSmithKline and Regulus Therapeutics form strategic alliance
- Bayer donates €250,000 for patients with hemophilia
- Grindeks JSC is opening new representative office in Uzbekistan